Table of Content

Part 1. Introduction
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive Summary

Part 4. Market Overview
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic

Part 5. Global Market for Anti-Rheumatics by Drug Class
5.1 Corticosteroids
5.1.1 Market Size and Forecast
5.2 Disease Modifying Anti-Rheumatic Drugs
5.2.1 Market Size and Forecast
5.3 Nonsteroidal Anti-Inflammatory Drugs
5.3.1 Market Size and Forecast
5.4 Uric Acid Drugs
5.4.1 Market Size and Forecast
5.5 Others
5.5.1 Market Size and Forecast

Part 6. Global Market for Anti-Rheumatics by Type
6.1 Over-The-Counter Drugs
6.1.1 Market Size and Forecast
6.2 Prescription-Based Drugs
6.2.1 Market Size and Forecast

Part 7. Global Market for Anti-Rheumatics by Region
7.1 Asia-Pacific
7.1.1 Market Size and Forecast
7.2 Europe
7.2.1 Market Size and Forecast
7.3 North America
7.3.1 Market Size and Forecast
7.4 Middle East And Africa (Mea)
7.4.1 Market Size and Forecast
7.5 South America
7.5.1 Market Size and Forecast

Part 8. Key Competitor Profiles
8.1 AbbVie Inc.
8.2 Amgen Inc.
8.3 Bristol Myers Squibb (BMS)
8.4 Eli Lilly And Company
8.5 Johnson & Johnson
8.6 Merck & Co., Inc.
8.7 Novartis AG
8.8 Pfizer Inc.
8.9 Roche Holding AG
8.10 UCB SA
*LIST IS NOT EXHAUSTIVE

Part 9. Patent Analysis
9.1 Patent Statistics
9.2 Regional Analysis
9.3 Trends Analysis

DISCLAIMER
ABOUT GEN CONSULTING COMPANY